Our Services
Medical Information
Helpful Resources
Published on: 3/11/2026
Rituximab side effects happen because depleting CD20 positive B cells shifts immunity and can trigger cytokine release, leading most often to infusion reactions, fatigue, rashes, and higher infection risk, with rare but serious issues like hepatitis B reactivation, low blood counts, heart or lung problems, and PML.
Medically approved steps include hepatitis B screening, premedication before infusions, vaccines before starting, regular labs, and clear plans for when to monitor at home, call your doctor for fever or other infection signs, or seek emergency care for trouble breathing or chest pain. There are several factors to consider, and the full list of symptoms to watch for and exact next steps is outlined below.
Rituximab is a powerful medication used to treat several autoimmune diseases and certain cancers. It is commonly prescribed for:
While rituximab can be highly effective, it can also cause side effects. Understanding why these side effects happen — and what to do about them — can help you feel more informed and prepared.
Rituximab is a monoclonal antibody. It targets a protein called CD20 found on the surface of B cells, a type of white blood cell.
B cells are part of your immune system. In autoimmune diseases like rheumatoid arthritis, B cells mistakenly attack healthy tissue. Rituximab works by:
This process is helpful — but it also temporarily weakens part of your immune system. That immune shift explains many rituximab side effects.
Most people tolerate rituximab well. However, side effects can occur, especially during or shortly after infusions.
These usually happen during the first infusion and are often mild to moderate.
Symptoms may include:
Why it happens:
When rituximab binds to B cells, it can trigger the release of inflammatory chemicals (cytokines). This is sometimes called a cytokine release reaction.
What doctors do:
Most infusion reactions improve with these steps.
Because rituximab reduces B cells, your immune system becomes less effective at fighting certain infections.
Common infections include:
Less common but serious risks:
Doctors screen for hepatitis B before starting rituximab. This is standard practice and very important.
Rituximab can sometimes cause:
These changes may not cause symptoms but can increase infection or bleeding risk.
Regular blood tests are used to monitor this.
Many patients report feeling tired after rituximab infusions.
Possible reasons include:
Fatigue usually improves over time.
Some people experience:
If you notice blistering, peeling skin, or widespread rash, contact a doctor immediately.
In rare cases, rituximab may cause:
These require urgent medical attention.
Rituximab is often used for moderate to severe rheumatoid arthritis when other treatments have not worked.
In RA patients, common side effects include:
Because rheumatoid arthritis already affects the immune system, careful monitoring is especially important.
If you're experiencing unexplained joint pain, morning stiffness, or persistent swelling and want to better understand whether these symptoms align with Rheumatoid Arthritis (RA), a free AI-powered symptom checker can help you assess your condition and guide your next steps.
To understand rituximab side effects, it helps to understand immune balance.
When B cells are destroyed:
Your body reacts because it recognizes rapid immune change.
In most cases, the body adapts over time.
However, people with:
may have a higher risk of complications.
If you are experiencing rituximab side effects, here's what to do:
For mild issues like fatigue or minor rash:
Do not ignore symptoms — but mild reactions are often manageable.
Contact your healthcare provider if you develop:
Infections can progress faster in patients on rituximab.
Early treatment is important.
Go to the emergency room or call emergency services if you experience:
These could be life-threatening and require urgent medical attention.
Physicians follow evidence-based guidelines to improve safety.
These steps often include:
These strategies significantly reduce risk.
For many patients, rituximab provides major relief from autoimmune disease or cancer progression.
Long-term safety data show:
The benefits often outweigh the risks — but that decision is individualized.
You should always speak to a doctor if:
Anything that could be life-threatening or serious requires immediate medical evaluation.
Never stop rituximab without medical guidance.
Rituximab is a powerful and targeted therapy. Its side effects occur because it intentionally alters part of your immune system — specifically B cells. Most reactions are mild and manageable. Some are serious but rare.
Understanding the reasons behind these effects can help reduce fear while encouraging appropriate caution.
If you are living with rheumatoid arthritis or another autoimmune disease and considering rituximab, informed conversations with your healthcare provider are essential.
Monitor your symptoms. Keep your appointments. And always speak to a doctor about anything that could be serious or life-threatening.
With proper oversight, rituximab remains an important and often highly effective treatment option.
(References)
* Modi, M., & Vazirani, J. (2020). Adverse Events Associated With Rituximab and Their Management. *Journal of Clinical Hematology and Therapeutics*, *18*(4), 160-167. https://pubmed.ncbi.nlm.nih.gov/32675762/
* Tiu, T., Chen, Z., & Prystowsky, M. B. (2020). Rituximab-Associated Acute Infusion Reactions: A Review of Risk Factors, Mechanisms, and Management. *Annals of Pharmacotherapy*, *54*(8), 819-830. https://pubmed.ncbi.nlm.nih.gov/32098492/
* Chirmule, N., & Ryman, J. T. (2019). Immunogenicity of rituximab and its clinical implications. *Therapeutic Advances in Pharmacological Sciences*, *2*(1), 1-13. https://pubmed.ncbi.nlm.nih.gov/32676742/
* Laccetti, C., Scarlata, S., Saraceni, V., & Pedone, C. (2018). Management of infusion-related reactions to rituximab: a practical approach. *Journal of Asthma and Allergy*, *11*, 223-231. https://pubmed.ncbi.nlm.nih.gov/30498305/
* Park, J. H., Kim, Y. B., & Choi, S. H. (2021). Clinical Safety and Efficacy of Rituximab Biosimilars: An Update. *Biologics: Targets and Therapy*, *15*, 239-251. https://pubmed.ncbi.nlm.nih.gov/34295191/
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.